Cityblock Exec Details Expansion of Advanced Behavioral Health Program
Program is designed to boost access to interventions such as long-acting injectable antipsychotics and medications for opioid use disorder and alcohol use disorder
Read More
Prospect Medical Holdings Files for Chapter 11 Bankruptcy
Beleaguered for-profit hospital system will seek to sell off remaining operations outside of California
Prioritize Provider Data for Seamless M&A Success
Health systems preparing for an M&A, or even those not immediately considering one, must prioritize a robust workforce data strategy. This approach is essential for navigating today’s increasingly frequent healthcare consolidations. The post Prioritize Provider Data for Seamless M&A Success appeared first on MedCity News.
AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive!
AI is the next big thing, and most developers want to protect those programs and systems. The answer is intellectual property protection and specifically patent protection. The post AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive! appeared first on MedCity News.
Trump’s Return Puts Medicaid on the Chopping Block
Under President Joe Biden, enrollment in Medicaid hit a record high and the uninsured rate reached a record low. Donald Trump’s return to the White House — along with a GOP-controlled Senate and House of Representatives — is expected to change that. Republicans in Washington say they plan to use funding cuts and regulatory changes…
Can Medical Schools Funnel More Doctors Into the Primary Care Pipeline?
Throughout her childhood, Julia Lo Cascio dreamed of becoming a pediatrician. So, when applying to medical school, she was thrilled to discover a new, small school founded specifically to train primary care doctors: NYU Grossman Long Island School of Medicine. Now in her final year at the Mineola, New York, school, Lo Cascio remains committed…
Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target
Gilead Sciences is acquiring LEO Pharma’s oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Morgan Healthcare Conference. The post Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt…
HHS’ Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply
HHS is proposing major changes to HIPAA for the first time in more than a decade, aiming to strengthen cybersecurity protocols for electronic health data. Healthcare cybersecurity leaders are mainly in favor of the proposal — though there are some concerns that smaller providers will struggle with the financial and operational burdens of compliance. The…
Mental Health Data Sells, But Who’s Buying?
Implementing a thorough federal privacy law and broadening HIPAA protections to include new mHealth technologies are crucial steps in enhancing personal data security. Equally important, companies and developers should adhere to strict ethical standards and robust security protocols during app development to protect users’ sensitive information. The post Mental Health Data Sells, But Who’s Buying?…
Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare
AI holds a lot of promise in supporting employer-sponsored healthcare, including improving patient navigation and billing, according to a new report from Morgan Health. The post Morgan Health: 5 Ways AI Can Improve Employer-Sponsored Healthcare appeared first on MedCity News.